📰 Evelop News
Page 82 - Evelop News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evelop. Real-time updates on events, politics, business and more.
September 16, 2022
Argentine seed technology firm Bioceres said on Friday it had agreed to expand its collaboration with Swiss seeds and pesticides maker Syngenta to develop and market its biological seed treatment... | September 16, 2022
September 15, 2022
AMSTERDAM and AUCKLAND, New Zealand, Sept. 15, 2022 /PRNewswire/ -- Sophie's Bionutrients and NewFish, two pioneers in the field of microalgae protein fermentation, with the support of New Zealand-based
September 14, 2022
In order to curb the negative effects of climate change-we must develop new technologies that enable the reduction of greenhouse gas emissions to zero. A powerful method for achieving... | September 14, 2022
September 14, 2022
Initial development and validation of clinical trial assay Next-generation sequencing (NGS) based assay targeting LRRK2 from blood samples Collaboration expands QIAGEN's NGS testing
September 14, 2022
By Rhiannon Hoyle Rio Tinto PLC on Wednesday said it intends to form a joint venture with China Baowu Steel Group Corp. Ltd. to develop the $2-billion Western Range iron-ore project in... | September 13, 2022
September 14, 2022
Adden Energy, a Harvard-based start-up, introduces a new type of battery called the solid-state battery.
September 14, 2022
BARCELONA, Spain, Sept. 14, 2022 /PRNewswire/ -- Fractus and the Universitat Politecnica de Catalunya - BarcelonaTech (UPC) have agreed to create the Fractus-UPC Deep Tech Hub, a center of research
September 13, 2022
Metabolon collaboration will combine metabolomics with neurological and clinical phenotyping to develop new biomarkers MORRISVILLE, N.C., Sept. 13, 2022 /PRNewswire/ -- Metabolon, Inc.
September 12, 2022
Autonomous vehicle startups have raised tens of billions of dollars based on promises to develop truly self-driving cars, but industry executives and experts say remote human supervisors may be... | September 12, 2022
September 12, 2022
Today Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, and Relay Therapeutics (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process